← Back to Search

HHD Measurement for Muscle Strength in Stroke Patients

N/A
Recruiting
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to follow two-step commands
Age 18 years or older
Must not have
Active infection and/or injury at location of testing site
Lower extremity contractures preventing full passive range of motion (ROM)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if HHD can more accurately measure leg muscle strength in stroke patients to better inform therapy.

Who is the study for?
This trial is for adults over 18 who've had a stroke at least 3 months ago and can follow simple commands. They must be able to hold certain positions like sitting or lying down during tests. People with severe limb stiffness, unstable vital signs, symptoms like shortness of breath or dizziness, active infections at the test site, or other serious health issues affecting physical activity cannot join.
What is being tested?
The study is testing if hand-held dynamometry (HHD), a tool for measuring muscle strength in the legs, can provide accurate data for therapists treating patients with chronic stroke. It will measure normal values of leg muscle force in different ways to see how well it works.
What are the potential side effects?
There are no direct side effects mentioned from using HHD as it's a non-invasive measurement tool. However, participants may experience general fatigue or discomfort from maintaining test positions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can understand and follow two-step instructions.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have an infection or injury where the test will be done.
Select...
I cannot fully move my legs due to stiffness.
Select...
I do not have symptoms like severe shortness of breath, chest pain, dizziness, severe headaches, sudden weakness or numbness, or leg pain suggesting a deep vein clot.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hand-held Dynamometry Measurement of Average Force Production
Secondary study objectives
Hand-held Dynamometry Measurement of Peak Force Production
Other study objectives
Hand-held Dynamometry Measurement of Time to Peak Force

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Average Force ProductionExperimental Treatment1 Intervention
Average force production of bilateral lower extremities will be collected using the handheld dynamometer, Activbody Activ5.

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
908 Previous Clinical Trials
934,820 Total Patients Enrolled
12 Trials studying Stroke
5,996 Patients Enrolled for Stroke

Media Library

Average Force Production Clinical Trial Eligibility Overview. Trial Name: NCT05941962 — N/A
Stroke Research Study Groups: Average Force Production
Stroke Clinical Trial 2023: Average Force Production Highlights & Side Effects. Trial Name: NCT05941962 — N/A
Average Force Production 2023 Treatment Timeline for Medical Study. Trial Name: NCT05941962 — N/A
~5 spots leftby Jul 2025